Abstract
SummaryAn angiotensin II antagonist, l-sarcosine-8-alanine-angiotensin II, was infused intravenously into conscious dogs with experimental hypertension produced by renal artery constriction and unilateral nephrectomy. In dogs with malignant hypertension and elevated plasma renin activity, a decrease in arterial pressure was observed during infusion of the angiotensin II analog. However, in dogs that developed chronic hypertension of 2–7 weeks duration no decreases in arterial pressure occurred during infusion of this angiotensin II antagonist. Similarly, infusion of this compound into normal conscious dogs did not decrease arterial pressure. It is suggested that angiotensin II acts on receptors in arteriolar smooth muscle to increase peripheral resistance and arterial pressure in dogs with malignant hypertension, but chronic hypertension in the dog is maintained by other mechanisms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.